Version history

{
  "description": "APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.",
  "domain": "neurodegeneration",
  "status": "partially_addressed",
  "priority_score": 0.91,
  "importance_score": 0.85,
  "tractability_score": 0.75,
  "novelty_score": 0.65,
  "composite_score": 0.6587,
  "source": "agent_generated",
  "evidence_summary": "{\"hypothesis_matches\": [{\"id\": \"h-541d61c3\", \"title\": \"Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles\", \"target_gene\": \"APOE4\", \"target_pathway\": null, \"match_score\": 0.57, \"composite_score\": 0.5319094969453281, \"status\": \"proposed\"}, {\"id\": \"h-trem2-f48baa0c\", \"title\": \"TREM2-APOE4 Co-targeting \\u2014 Simultaneous Correction of Lipid Sensing and Clearance Deficits\", \"target_gene\": \"TREM2, APOE\", \"target_pathway\": \"lipid metabolism, amyloid clearance\", \"match_score\": 0.5, \"composite_score\": 0.4607042418580709, \"status\": \"proposed\"}, {\"id\": \"h-99b4e2d2\", \"title\": \"Interfacial Lipid Mimetics to Disrupt Domain Interaction\", \"target_gene\": \"APOE\", \"target_pathway\": \"Apolipoprotein E lipid transport\", \"match_score\": 0.5, \"composite_score\": 0.4047961202616306, \"status\": \"proposed\"}, {\"id\": \"h-11795af0\", \"title\": \"Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs)\", \"target_gene\": \"APOE\", \"target_pathway\": \"Apolipoprotein E lipid transport\", \"match_score\": 0.37, \"composite_score\": 0.5940704149617542, \"status\": \"proposed\"}, {\"id\": \"h-d0a564e8\", \"title\": \"Competitive APOE4 Domain Stabilization Peptides\", \"target_gene\": \"APOE\", \"target_pathway\": \"Apolipoprotein E lipid transport\", \"match_score\": 0.37, \"composite_score\": 0.5764005155895072, \"status\": \"proposed\"}, {\"id\": \"h-c9c79e3e\", \"title\": \"APOE4-Selective Lipid Nanoemulsion Therapy\", \"target_gene\": \"APOE\", \"target_pathway\": \"APOE-mediated cholesterol/lipid transport\", \"match_score\": 0.37, \"composite_score\": 0.4360731331239531, \"status\": \"proposed\"}, {\"id\": \"h-44195347\", \"title\": \"APOE4 Allosteric Rescue via Small Molecule Chaperones\", \"target_gene\": \"APOE\", \"target_pathway\": \"Apolipoprotein E lipid transport\", \"match_score\": 0.3, \"composite_score\": 0.520488824804739, \"status\": \"proposed\"}, {\"id\": \"h-a20e0cbb\", \"title\": \"Targeted APOE4-to-APOE3 Base Editing Therapy\", \"target_gene\": \"APOE\", \"target_pathway\": \"Apolipoprotein E lipid transport\", \"match_score\": 0.3, \"composite_score\": 0.4794740198496571, \"status\": \"proposed\"}, {\"id\": \"h-seaad-fa5ea82d\", \"title\": \"APOE Isoform Expression Across Glial Subtypes\", \"target_gene\": \"APOE\", \"target_pathway\": \"Lipid Metabolism / Cholesterol Transport\", \"match_score\": 0.3, \"composite_score\": 0.4443403342524345, \"status\": \"proposed\"}, {\"id\": \"h-69bde12f\", \"title\": \"APOE4-Lipid Metabolism Correction\", \"target_gene\": \"APOE\", \"target_pathway\": null, \"match_score\": 0.27, \"composite_score\": 0.40415125430326243, \"status\": \"proposed\"}], \"total_matching_hypotheses\": 16, \"gap_tokens_sample\": [\"APOE3\", \"APOE4\", \"C112R\", \"alters\", \"amyloid\", \"binding\", \"biology\", \"causing\", \"clearance\", \"differs\", \"domain\", \"interaction\", \"lipid\", \"strategies\", \"structural\"], \"updated_at\": \"2026-04-06T08:21:05.731690+00:00\"}",
  "resolution_criteria": "Resolved when: structural and functional evidence explains how APOE4 domain interaction changes lipid binding, amyloid/tau handling, or receptor interactions relative to APOE3, and identifies therapeutic strategies with model evidence. SciDEX must cite structures or biochemical studies, add KG edges linking APOE isoforms, structural features, lipidation pathways, receptors, and AD phenotypes, and produce a scored hypothesis or debate synthesis ranking interventions.",
  "market_price": 0.5
}